I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Low-Dose of Intrapulmonary Pirfenidone Improves Human Trans..:
Tomohito Okano
;
Tetsu Kobayashi
;
Taro Yasuma
...
https://www.frontiersin.org/articles/10.3389/fphar.2020.593620/full. , 2020
Link:
https://doi.org/10.3389/fphar.2020.593620
RT Journal T1
Low-Dose of Intrapulmonary Pirfenidone Improves Human Transforming Growth Factorβ1-Driven Lung Fibrosis
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:efcc9395978b4f508fef940bd7451fc3&Exemplar=1&LAN=DE A1 Tomohito Okano A1 Tetsu Kobayashi A1 Taro Yasuma A1 Corina N. D'Alessandro-Gabazza A1 Masaaki Toda A1 Hajime Fujimoto A1 Hiroki Nakahara A1 Yuko Okano A1 Atsuro Takeshita A1 Kota Nishihama A1 Haruko Saiki A1 Atsushi Tomaru A1 Valeria Fridman D'Alessandro A1 Satoru Ishida A1 Hiromi Sugimoto A1 Yoshiyuki Takei A1 Esteban C. Gabazza PB Frontiers Media S.A. YR 2020 K1 idiopathic pulmonary fibrosis K1 pirfenidone K1 intrapulmonary delivery K1 oral therapy K1 adverse effects K1 drug delivery K1 Therapeutics. Pharmacology K1 RM1-950 JF https://www.frontiersin.org/articles/10.3389/fphar.2020.593620/full LK http://dx.doi.org/https://doi.org/10.3389/fphar.2020.593620 DO https://doi.org/10.3389/fphar.2020.593620 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)